Search clinical trials for: FOLFOX 4

Total 5855 results

Jules Bordet Institute

Completed

Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer (PePiTA)

Colon Cancer

Belgium
Binex

Unknown

Efficacy Study of TKcell in Advanced Colorectal Cancer

Advanced Colorectal Cancer

Korea, Republic of
Binex

Unknown

Efficacy Study of TKcell in Advanced Gastric Cancer

Advanced Gastric Cancer

Korea, Republic of
Sun Yat-sen University

Unknown

Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection

Carcinoma, Hepatocellular

China
Sanofi

Completed

Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer

Esophageal Neoplasms

France
Centre Georges Francois Leclerc
Federation Francophone de Cancerologie Digestive; National Cancer Institute... and other collaborators

Completed

Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus (CONCORDE)

Esophageal Cancer

France
Fujian Medical University Union Hospital

Recruiting

Short-course Radiotherapy (5×6Gy/7Gy/8Gy) Followed by Neo-adjuvant Chemotherapy for Locally Advanced Rectal Cancer

Rectal Cancer | Radiation Oncology

China
Hospital Universitari de Bellvitge
Instituto de Salud Carlos III

Terminated

Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases (CCRe-IV)

Colonic Cancer | Unresectable Metastasis Originating in Colonic Cancer

Spain
Ain Shams University

Recruiting

the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin

Gastrointestinal Cancer

Egypt
Spanish Cooperative Group for the Treatment of...
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer

Colorectal Cancer

Spain
University of Chicago
National Institutes of Health (NIH); University of Houston

Not yet recruiting

Quantitative Assessment of Autologous Fat Transfer

Autologous Fat Grafting
Assistance Publique - Hôpitaux de Paris
Federation Francophone de Cancerologie Digestive; UNICANCER; Merck Serono S.A... and other collaborators

Unknown

Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer (ECKINOXE)

Colon Cancer | Locally Advanced Malignant Neoplasm

France
Spanish Cooperative Group for the Treatment of...
Amgen

Completed

Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer and Liver-only Metastases (PLANET)

Colorectal Cancer

Spain
Fudan University

Unknown

Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal Cancer

Colorectal Cancer | Liver Metastasis

China
Amgen

Completed

PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study

Colorectal Cancer
Hospices Civils de Lyon

Completed

Assessment of a Multidisciplinary Team Meeting (RCP) in Geriatric Oncology (EROG)

Cancer

France
Karen-Lise Garm Spindler

Recruiting

IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (IMPROVE-IT)

Colorectal Cancer | Adjuvant Chemotherapy | Circulating Tumor DNA | Progression Free Survival

Denmark
Fox Chase Cancer Center

Suspended

Organ Preservation in Early Rectal Cancer Patients

Rectal Cancer

United States
Five Prime Therapeutics, Inc.

Completed

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer (FIGHT)

Gastric Cancer | Gastrointestinal Cancer | Gastrointestinal Cancer Metastatic

United States
Amgen Research (Munich) GmbH

Completed

Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases (MT201-204)

Colorectal Cancer | Liver Metastases

Germany, France
University of Saskatchewan

Terminated

FOLFIRI Alternate With FOLFOX in Untreated Metastatic Gastric and Esophageal Adenocarcinoma (LOGIC)

Metastatic Gastro-esophageal Adenocarcinoma

Canada
Canadian Cancer Trials Group

Active, not recruiting

NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer

Rectal Cancer

United States, Canada
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.

Colorectal Cancer

Canada, Australia, New Zealand
Five Prime Therapeutics, Inc.
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer (FIGHT)

Gastric Cancer

United States, Spain, China, Italy, Korea, Republic of, Portugal, Taiwan, Japan, Turkey, France, Hungary, Thailand, Germany, Poland, Australia, Belgium, Romania, United Kingdom
Institut du Cancer de Montpellier - Val d'Aurelle
Sanofi; Pfizer; Chugai Pharmaceutical

Completed

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Colorectal Cancer | Chemotherapy | Liver Metastases

France
University of Iowa

Completed

Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Anxiety

Post Partum Depression | Perinatal Depression | Perinatal Anxiety | Post Partum Anxiety

United States
Centre Hospitalier Universitaire Dijon

Completed

Evaluation of Bevacizumab in Combination With First-Line Chemotherapy in Patients Aged 75 Years of Older With Metastatic Colorectal Adenocarcinoma (Prodige20) (Prodige20)

Metastatic Colorectal Adenocarcinoma

France
Sun Yat-sen University

Recruiting

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Hepatocellular Carcinoma

China
Sirtex Medical

Completed

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer (SIRFLOX)

Colorectal Cancer | Liver Metastases | Colorectal Carcinoma

United States, Israel, Australia, Belgium, New Zealand, Spain, Germany, Switzerland, Italy, France, Poland
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers (ARMANI)

Stomach Neoplasms

Italy
Fudan University

Not yet recruiting

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

Colorectal Cancer | Liver Metastases

China
Pharma Holdings AS
CTC Clinical Trial Consultants AB

Completed

Study to Evaluate the Efficacy, Safety and Tolerability of 3% LTX-109 for Nasal Decolonisation of Staphylococcus Aureus

Nasal Decolonization of Staphylococcus Aureus

Sweden
Janssen Research & Development, LLC

Completed

A Study in Healthy Adults to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860

Healthy

United States
Immunovative Therapies, Ltd.
Mirror Biologics, Inc.

Recruiting

Immunotherapy for Advanced Liver Cancer (ALIVE)

Hepatocellular Carcinoma

Thailand, Malaysia
Amgen

Completed

Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer

Rectal Cancer | Colon Cancer
MedImmune LLC

Withdrawn

Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC

Microsatellite-stable Colorectal Cancer
Maisonneuve-Rosemont Hospital

Completed

Inspiratory Support Improves Preoxygenation in Healthy Subjects

Healthy

Canada
Assistance Publique - Hôpitaux de Paris
GERCOR - Multidisciplinary Oncology Cooperative Group

Completed

FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer (FOLFOX)

Esophageal Cancer Stage III

France
Erasmus Medical Center
Chiesi Farmaceutici S.p.A.

Completed

Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumonia (VAPORISE)

Ventilator Associated Pneumonia (VAP)

Spain, Netherlands
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Sequential Treatment Strategy for Metastatic Colorectal Cancer (ITACa)

Metastatic Colorectal Cancer

Italy
Beijing Tsinghua Chang Gung Hospital

Recruiting

Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma, Intrahepatic

China
Jeffrey A. Cohen, MD
Jacobus Pharmaceutical

Terminated

Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS) (3-4DAP)

Muscle Weakness

United States
University of Utah
Novartis

Withdrawn

BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers (BKM120)

Endometrial Cancer

United States
Centre Hospitalier Universitaire de Nīmes

Completed

Low Energy Shockwave Therapy for Improving Erectile Dysfunction (Shock-ED)

Erectile Dysfunction

France
University of Rochester

Active, not recruiting

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

Advanced Rectal Cancer

United States
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Interval Training and Resting Metabolism (NEAT)

Healthy Subjects

Norway
University of Washington

Recruiting

Prospective Case Series to Refine Standalone Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue

Multiple Sclerosis | Fatigue

United States
Institut Straumann AG

Active, not recruiting

4 mm Implants in Fixed Cross-Arch Prostheses

Jaw Edentulous

Switzerland, United Kingdom
University Hospital, Strasbourg, France

Completed

Muscle Blood Flow During Exercise

Skeletal Muscle Blood Flow

France
DEKK-TEC, Inc.

No longer available

A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers

Advanced Cancer

United States

Search clinical trials for: FOLFOX 4

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations